Ultra-early hemostatic therapy for intracerebral hemorrhage

Stroke

Volumn 34, Issue 1, 2003, Pages 224-229

  Mayer, Stephan A ^a  

^a NONE

Author keywords

Cerebral hemorrhage; Factor VIIa; Hemostasis; Stroke management

Indexed keywords

AMINOCAPROIC ACID; APROTININ; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9 CONCENTRATE; DESMOPRESSIN; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; WARFARIN;

BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; HEMOSTASIS; HUMAN; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM;

EID: 0037229469     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000046458.67968.E4     Document Type: Review

References (76)

1. Sacco RL, Mayer SA. Epidemiology of intracerebral hemorrhage. In: Feldmann E, ed. Intracerebral Hemorrhage. Armonk, NY: Futura Publishing Co; 1994:3-23.
2. Broderick JP, Adams HP Jr, Barsan W, Feinberg W, Feldmann E, Grotta J, Kase C, Krieger D, Mayberg M, Tilley B, Zabramski JM, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council. American Heart Association. Stroke. 1999;30:905-915.
3. Mayer SA, Copeland DL, Bernardini GL, Boden-Albala B, Lennihan L, Kossoff S, Sacco RL. Cost and outcome of mechanical ventilation for life-threatening stroke. Stroke. 2000;31:2346-2353.
4. Gujjar AR, Deibert E, Manno EM, Duff S, Diringer MN. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology. 1998;51:447-451.
5. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450-1460.
6. Bonita R. Epidemiology of stroke. Lancet. 1992;339:342-344.
7. Tellez H, Bauer R. Dexamethasone as treatment in cerebrovascular disease, I: a controlled study in intracerebral hemorrhage. Stroke. 1973;4:541-546.
8. Poungvarin N, Bhoopat W, Viriyavejakul A, Rodprasert P, Buranasiri P, Sukondhabhant S, Hensley MJ, Strom BL. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med. 1987;316:1229-1233.
9. Yu YL, Kumana CR, Lauder IJ, Cheung YK, Chan FL, Kou M, Chang CM, Cheung RTF, Fong KY. Treatment of acute cerebral hemorrhage with intravenous glycerol: a double-blind, placebo-controlled, randomized trial. Stroke. 1992;23:967-971.
10. Fernandes HM, Gregson B, Siddique S, Mendelow AD. Surgery in intracerebral hemorrhage; the uncertainty continues. Stroke. 2000;31:2511-2516.
11. Montes JM, Wong JH, fayad PB, Awad IA. Stereotactic computed-tomographic aspiration and thrombolysis of intracerebral hematoma: protocol and preliminary experience. Stroke. 2000;31:834-840.
12. Naff NJ, Carhuapoma JR, Williams MA, Bhardwaj A, Ulatowski JA, Bederson J, Bullock R, Schmutzhard E, Pfausler B, Keyl PM, Tuhrim S, Hanley DF. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke. 2000;31:841-847.
13. Coplin WM, Vinas FC, Agris JM, Buciuc R, Michael DB, Diaz FG, Muizelaar JP. A cohort study of the safety and feasibility of intraventricular urokinase for non-aneurysmal spontaneous intraventricular hemorrhage. Stroke. 1998;29:1573-1579.
14. Kase C, Mohr JP. General features of intracerebral hemorrhage. In: Barnett H, Stein B, Mohr JP, eds. Stroke: Pathophysiology, Diagnosis and Management. New York, NY: Churchill Livingstone; 1986:497-523.
15. Chen ST, Chen SD, Hsu CY, Hogan EL. Progression of hypertensive intracerebral hemorrhage. Neurology. 1989;39:1509-1514.
16. Broderick JP, Brott TG, Tomsick T, Barsan W, Spilker J. Ultra-early evaluation of intracerebral hemorrhage. J Neurosurg. 1990;72:195-199.
17. Kelley RE, Berger JR, Scheinberg P, Stokes N. Active bleeding in hypertensive intracerebral hemorrhage: computed tomography. Neurology. 1982;32:852-856.
18. Bae HG, Lee KS, Yun IG, Bae WK, Choi SK, Byun BJ, Lee IS. Rapid expansion of hypertensive intracerebral hemorrhage. Neurosurgery. 1992;31:35-41.
19. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
20. Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O. Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg. 1994;80:51-57.
21. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke. 1998;29:1160-1166.
22. Fujitsu K, Muramoto M, Ikeda Y, Inada Y, Kim I, Kuwabara T. Indications for surgical treatment of putaminal hemorrhage: comparative study based on serial CT and time-course analysis. J Neurosurg. 1990;73:518-525.
23. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage: incidence and time course. Stroke. 1996;27:1783-1787.
24. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1997;28:2370-2375.
25. Murai Y TR, Ikeda Y, Yamamoto Y, Teramoto A. Three-dimensional computerized tomography angiography in patients with hyperacute intracerebral hemorrhage. J Neurosurg. 1999;91:424-431.
26. Becker KJ, Baxter AB, Bybee HM, Tirschwell DL, Abouelsaad T, Cohen WA. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke, 1999;30:2025-2032.
27. Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology. 2001;56:1294-1299.
28. Kaneko M, Tabaka K, Shimada T, Sato K, Uemura K. Long-term evaluation of ultra-early operation for hypertensive intracerebral hemorrhage in 100 cases. J Neurosurg. 1983;58:838-842.
29. Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol. 1971;30:536-550.
30. Mayer SA, Lignelli A, Fink ME, Kessler DB, Thomas CE, Swarup R, Van Heertum RL. Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study. Stroke. 1998;29:1791-1798.
31. Mizukami M, Araki G, Mihara H, Tomita T, Fujinaga R. Arteriographically visualized extravasation in hypertensive intracerebral hemorrhage: report of seven cases. Stroke. 1972;3:527-537.
32. Komiyama M, Yasui T, Tamura K, Nagata Y, Fu Y, Yagura H. Simultaneous bleeding from multiple lenticulostriate arteries in hypertensive intracerebral haemorrhage. Neuroradiology. 1995;37:129-130.
33. Kowada M, Yamaguchi K, Matsuoka S, Ito Z. Extravasation of angiographic contrast material in hypertensive intracerebral hemorrhage. J Neurosurg. 1972;36:471-473.
34. Huckman MS, Weinberg PE, Kim KS, Davis DO. Angiographic and clinico-pathologic correlates in basal ganglionic hemorrhage. Radiology. 1970;95:79-92.
35. Wolpert SM, Schatzki SC. Extravasation of contrast material in the intracerebral basal ganglia. Radiology. 1972;102:83-85.
36. Zazulia AR, Diringer MN, Videen TO, Adams RE, Yundt K, Aiyagari V, Grubb RL, Powers WJ. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804-810.
37. Carhuapoma JR, Wang PY, Beauchamp NJ, Keyl PM, Hanley DF, Baker PB. Diffusion-weighted MRI and proton MR spectroscopic imaging in the study of secondary neuronal injury after intracerebral hemorrhage. Stroke. 2000;31:726-732.
38. Nath FP, Kelly PT, Jenkins A, Mendelow AD, Graham DI, Teasdale GM. Effects of experimental intracerebral hemorrhage on blood flow, capillary permeability, and histochemistry. J Neurosurg. 1987;66:555-562.
39. Takasugi S, Ueda S, Matsumoto K. Chronological changes in spontaneous intracerebral hemorrhage: an experimental and clinical study. Stroke. 1985;16:651-658.
40. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE, Broderick JP, Brott TG. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke. 1996;27:490-497.
41. Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg. 1996;84:91-96.
42. Gong C HJ, Keep RF. Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res. 2000;871:57-65.
43. Xi G, Wagner KR, Keep RF, Hua Y, de Courten-Myers G, Broderick JP, Brott TG, Hoff JT. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke. 1998;29:2580-2586.
44. Jenkins A, Mendelow AD, Graham DI, Nath FP, Teasdale GM. Experimental intracerebral haematoma: the role of blood constituents in early ischaemia. Br J Neurosurg. 1990;4:45-51.
45. Rosenberg GA, Navratil M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology. 1997;48:921-926.
46. Yang GY, Betz AL, Chenevert TL, Brunberg JA, Hoff JT. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg. 1994;81:93-102.
47. Olson JD. Mechanisms of hemostasis: effects on intracerebral hemorrhage. Stroke. 1993;23(suppl I):I-109-I-114.
48. Tuhrim S, Dambrosia JM, Price TR, Mohr JP, Wolf PA, Heir DB, Kase CS. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol. 1991;29:658-663.
49. Portenoy RK, Lipton RB, Berger AR, Lesser ML, Lantos G. Intracerebral hemorrhage; a model for prediction of outcome. J Neurol Neurosurg Psychiatry. 1987;50:976-979.
50. Daverat P, Castel JP, Dartigues JF, Orgogozo JM. Death and functional outcome after spontaneous intracerebral hemorrhage: a prospective study of 166 cases using multivariate analysis. Stroke. 1991;22:1-6.
51. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987-993.
52. Alberts MJ, Bertels C, Dawson DV. An analysis of time of presentation after stroke. JAMA. 1990;263:65-68.
53. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology. 1994;44:1379-1384.
54. Fredriksson K, Norrving B, Strömblad L-G. Emergency reversal of anti-coagulation after intracerebral hemorrhage. Stroke. 1992;23:972-977.
55. Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery. 1999;45:1113-1119.
56. Yeston NS, Niehoff JM, Dennis RC. Transfusion therapy. In: Civetta JM, Taylor RW, Kirby RR, eds. Critical Care. 2nd ed. Philadelphia, Pa: JB Lippincott Co; 1992:427-433.
57. Mannucci PM. Hemostatic drugs. N Engl J Med. 1998;339:245-253.
58. Hedner U, Ingerslev J. Clinical use of recombinant FVIIa (rFVIIa). Transfus Sci. 1998;19:163-176.
59. Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis. 1998;9(suppl 1):S147-S152.
60. Weiss HJ, Turitto VT, Baumgartner HR, Nemerson Y, Hoffmann T. Evidence for the presence of tissue factor activity on subendothelium. Blood. 1989;73:968-975.
61. Monroe DM, Hoffman M, Oliver JA, Roberts HR. A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis. 1998;9(suppl 1):S15-S20.
62. Lusher J, Ingerslev J, Roberts H, Hedner U. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinolysis. 1998;9:119-128.
63. Hedner U, Erhardtsen E. Potential role for rFVIIa in transfusion medicine. Transfusion. 2002;42:114-124.
64. Rice KM, Savidge GF. NovoSeven (recombinant factor VIIa) in central nervous systems bleeds. Haemostasis. 1996;26(suppl 1):131-134.
65. Arkin S, Cooper HA, Hutter JJ, Miller S, Schmidt ML, Seibel NL, Shapiro A, Warrier I. Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors: results of the NovoSeven emergency-use program. Haemostasis. 1998;28:93-98.
66. Schmidt ML, Gamerman S, Smith HE, Scott JP, DiMichele DM. Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors. Am J Hematol. 1994;47:36-40.
67. Friederich PW, Geerdink MG, Spataro M, Messelink EJ, Henny CP, Buller HR, Levi M. The effect of the administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study. Blood Coagul Fibrinolysis. 2000;11(suppl 1):S129-S132.
68. Lindley CM, Sawyer WT, Macik BG, Lusher J, Harrison JF, Baird-Cox K, Birch K, Glazer S, Roberts HR. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther. 1994;55:638-648.
69. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ. 1996;313:579-582.
70. Henry DA, O'Connell DL. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. BMJ. 1989;298:1142-1146.
71. Walsh PN, Rizza CR, Matthews JM, Eipe J, Kernoff PB, Coles MD, Bloom AL, Kaufman BM, Beck P, Hanan CM, Biggs R. Epsilon-aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial. Br J Haematol. 1971;20:463-475.
72. Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, Schannong M, Teasdale GM, van Crevel H, van Gijn J. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med. 1984;311:432-437.
73. Kassel NF, Torner JC, Adams HP. Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage: preliminary observations from the cooperative aneurysm study. J Neurosurg. 1984;61:225-230.
74. Tsementzis SA, Hitchcock ER, Meyer CHA. Benefits and risks of anti-fibrinolytic therapy in the management of ruptured intracranial aneurysms. Acta Neurochir (Wien). 1990;102:1-10.
75. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987;2:1289-1291.
76. Neuhaus P, Bechstein WO, Lefebre B, Blumhardt G, Slama K. Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet. 1989;2:924-925.